Hyperinsulinemia. A link between hypertension obesity and glucose intolerance - PubMed (original) (raw)
- PMID: 3884667
- PMCID: PMC423608
- DOI: 10.1172/JCI111776
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance
M Modan et al. J Clin Invest. 1985 Mar.
Abstract
Hypertension and glucose intolerance, determined in a random population sample (n = 2,475), showed a highly significant (P less than 0.001) association from the mildest levels of both conditions, independent of the confounding effects of age, sex, obesity, and antihypertensive medications. Summary rate ratios for hypertension were 1.48 (1.18-1.87) in abnormal tolerance and 2.26 (1.69-2.84) in diabetes compared with normal tolerance. Altogether, 83.4% of the hypertensives were either glucose-intolerant or obese--both established insulin-resistant conditions. Fasting and post-load insulin levels in a representative subgroup (n = 1,241) were significantly elevated in hypertension independent of obesity, glucose intolerance, age, and antihypertensive medications. The mean increment in summed 1- and 2-h insulin levels (milliunits per liter) compared with nonobese normotensives with normal tolerance was 12 for hypertension alone, 47 for obesity alone, 52 for abnormal tolerance alone, and 124 when all three conditions were present. The prevalence of concentrations (milliequivalents per liter) of erythrocyte Na+ greater than or equal to 7.0, K+ less than 92.5, and plasma K+ greater than or equal to 4.5 in a subsample of 59 individuals with all combinations of abnormal tolerance obesity and hypertension was compared with those in 30 individuals free of these conditions. Altogether, 88.1% of the former vs. 40.0% of the latter group presented at least one of these three markers of internal cation imbalance (P less than 0.001). We conclude that insulin resistance and/or hyperinsulinemia (a) are present in the majority of hypertensives, (b) constitute a common pathophysiologic feature of obesity, glucose intolerance, and hypertension, possibly explaining their ubiquitous association, and (c) may be linked to the increased peripheral vascular resistance of hypertension, which is putatively related to elevated intracellular sodium concentration.
Similar articles
- Hyperinsulinemia--a link between glucose intolerance, obesity, hypertension, dyslipoproteinemia, elevated serum uric acid and internal cation imbalance.
Modan M, Halkin H, Fuchs Z, Lusky A, Chetrit A, Segal P, Eshkol A, Almog S, Shefi M. Modan M, et al. Diabete Metab. 1987 Jul;13(3 Pt 2):375-80. Diabete Metab. 1987. PMID: 3308568 - Altered erythrocyte and plasma sodium and potassium in hypertension, a facet of hyperinsulinemia.
Halkin H, Modan M, Shefi M, Almog S. Halkin H, et al. Hypertension. 1988 Jan;11(1):71-7. doi: 10.1161/01.hyp.11.1.71. Hypertension. 1988. PMID: 3338841 - Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians.
Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. Saad MF, et al. Diabetes. 1990 Nov;39(11):1430-5. Diabetes. 1990. PMID: 2227116 - [Insulin resistance and arterial hypertension].
Weidmann P, Müller-Wieland D, de Courten M, Krone W. Weidmann P, et al. Herz. 1995 Feb;20(1):16-32. Herz. 1995. PMID: 7713473 Review. German. - Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension.
Modan M, Halkin H. Modan M, et al. Diabetes Care. 1991 Jun;14(6):470-87. doi: 10.2337/diacare.14.6.470. Diabetes Care. 1991. PMID: 1864220 Review.
Cited by
- Systematic Analysis of Integrated Gene Functional Network of Four Chronic Stress-related Lifestyle Disorders.
Roy S, Chakraborty A, Ghosh C, Banerjee B. Roy S, et al. Genome Integr. 2015 Apr 28;6:1. doi: 10.4103/2041-9414.155952. eCollection 2015. Genome Integr. 2015. PMID: 27330735 Free PMC article. - Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure.
Sakamoto M, Suzuki H, Hayashi T, Iuchi H, Isaka T, Sakamoto N, Kayama Y, Tojo K, Yoshimura M, Utsunomiya K. Sakamoto M, et al. Cardiovasc Diabetol. 2012 Oct 3;11:118. doi: 10.1186/1475-2840-11-118. Cardiovasc Diabetol. 2012. PMID: 23034088 Free PMC article. Clinical Trial. - Model-based in silico analysis of the PI3K/Akt pathway: the elucidation of cross-talk between diabetes and breast cancer.
Rehman S, Obaid A, Naz A, Ali A, Kanwal S, Ahmad J. Rehman S, et al. PeerJ. 2018 Nov 9;6:e5917. doi: 10.7717/peerj.5917. eCollection 2018. PeerJ. 2018. PMID: 30515357 Free PMC article. - Risk profiles for metabolic syndrome in a nonclinical sample of adolescent girls.
Ventura AK, Loken E, Birch LL. Ventura AK, et al. Pediatrics. 2006 Dec;118(6):2434-42. doi: 10.1542/peds.2006-1527. Pediatrics. 2006. PMID: 17142529 Free PMC article. - Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa.
Oguntola SO, Hassan MO, Duarte R, Vachiat A, Manga P, Naicker S. Oguntola SO, et al. BMC Nephrol. 2019 Oct 30;20(1):399. doi: 10.1186/s12882-019-1583-8. BMC Nephrol. 2019. PMID: 31666030 Free PMC article.
References
- Lancet. 1980 Jun 28;1(8183):1373-6 - PubMed
- Diabetologia. 1982 Jun;22(6):399-411 - PubMed
- Lancet. 1966 Jun 18;1(7451):1336-7 - PubMed
- Int J Epidemiol. 1978 Mar;7(1):15-24 - PubMed
- Am J Public Health. 1982 Apr;72(4):359-68 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical